Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions.

Hoeppli RE, MacDonald KN, Leclair P, Fung VCW, Mojibian M, Gillies J, Rahavi SMR, Campbell AIM, Gandhi SK, Pesenacker AM, Reid G, Lim CJ, Levings MK.

Am J Transplant. 2019 Jan;19(1):62-76. doi: 10.1111/ajt.14936. Epub 2018 Jun 13.

PMID:
29766641
2.

Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.

Tang AC, Rahavi SM, Fung SY, Lu HY, Yang H, Lim CJ, Reid GS, Turvey SE.

Cell Death Dis. 2018 Feb 7;9(2):162. doi: 10.1038/s41419-017-0194-1.

3.

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.

Chu TLH, Connell M, Zhou L, He Z, Won J, Chen H, Rahavi SMR, Mohan P, Nemirovsky O, Fotovati A, Pujana MA, Reid GSD, Nielsen TO, Pante N, Maxwell CA.

Mol Cancer Res. 2018 Jan;16(1):16-31. doi: 10.1158/1541-7786.MCR-17-0417. Epub 2017 Oct 9.

4.
5.

The stimulatory effect of CaCl(2), NaCl and NH(4)NO(3) salts on the ssDNA-binding activity of RecA depends on nucleotide cofactor and buffer pH.

Ziemienowicz A, Rahavi SM, Kovalchuk I.

BMB Rep. 2011 May;44(5):341-6. doi: 10.5483/BMBRep.2011.44.5.341.

Supplemental Content

Loading ...
Support Center